Shrier Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Shrier Wealth Management's ABBV Position: Q3 2026 in Review
Shrier Wealth Management reduced its AbbVie (ABBV) stake by 4.9% in Q3 2026, selling an estimated $37.9K and leaving 2,853 shares worth $746K. The position accounts for 0.25% of the portfolio, ranked #78.
Shrier Wealth Management first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $755K in Q2 2026. 4,278 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Shrier Wealth Management held 2,853 shares of AbbVie worth $746K as of Q3 2026.
- Shrier Wealth Management sold 148 AbbVie shares in Q3 2026, an estimated $37.9K.
- AbbVie made up 0.25% of Shrier Wealth Management's portfolio in Q3 2026, its #78 holding.
- Shrier Wealth Management first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
- Shrier Wealth Management's AbbVie position peaked at $755K in Q2 2026.
- 4,278 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Shrier Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.